TS7: Challenges for the biosciences Flashcards
(41 cards)
What is synthetic biology?
Uses nature’s solutions, deciphers these solutions, and re-purposes them for our own advantage.
What is a toggle switch in synthetic biology?
A synthetic, bistable gene-regulatory network that allows for gene expression to be turned on or off depending on the conditions applied.
Describe the process of a modern SynBio development.
- Design: AI/CAD tools and extensive sequence databases to find parts.
- Build: creating libraries rather than single constructs.
- Test: high precision single-cell analysis in bioreactors/robotics.
- Learn: support from algorithms with designs that learn on their own with directed evolution.
Why aren’t we good at synthetic biology?
- Complexity of cells
- Can’t predict intracellular responses
- Won’t work in all systems e.g., bacteria to human
- Cells have limited resources
- Cells have multiple interacting processes
- Changing behaviours can destabilize circuits
How can we overcome the issues facing synthetic biology?
Cell variability –> Feedback control: nature uses feedback control to deal with changing and complex environments without falling apart.
Combine the high-level programming of computers with the best parts of biological components.
What is steered evolution in synthetic biology?
Using technology to observe and optimize mutations and selection pressures to achieve the best possible solution, rather than an intermediate solution.
What’s the difference between vaccines and anti-malarial drugs?
Vaccines act via the immune system’s immunological memory. Anti-malarial drugs kill the parasite itself.
What is the difference between whole-organism and subunit vaccine approaches?
Whole-organism is the traditional approach where the whole organism is inactivated for vaccine use.
Subunit vaccine strategies identify a target from the pathogen and administer is with some signal to activate the immune system.
What is a human challenge study?
A clinical trial for a vaccine where healthy volunteers are vaccinated and then infected. The parasites are monitored by qPCR in the hopes that with a vaccine administered, there will be a reduction or elimination of the parasite.
What are transmission-blocking vaccines?
Type of vaccine that blocks the ability of diseases to infect others, rather than protecting the individual who receives the vaccine.
They work by stimulating the immune system to produce antibodies that specifically target the disease-causing organism and will enter the blood meal of the vector insect to bind the pathogen within the vector’s gut.
Describe the standard membrane feeding assay.
Technique to evaluate the efficacy of transmission-blocking vaccines.
Infected vectors are artificially fed a blood sample containing the TBV. At the end of an incubation period, the vectors are dissected and the number of parasites in the gut is quantified.
What are anti-sporozoite vaccines?
Vaccines that target the sporozoite stage of the malaria parasite’s life cycle.
Sporozoites are the form of malaria that are injected into the human bloodstream by the bite of an infected mosquito. Anti-sporozoite vaccines work by stimulating the immune system to produce antibodies that specifically target the sporozoites, preventing them from infecting liver cells and developing into the next stage of the malaria parasite’s life cycle.
What’s the difference between the RTS,S and R21 vaccine?
Both target the antigen on the surface of liver-invasive sporozoites, but R21 has more of the antigens present on its surface which gives it a much higher efficacy.
What is blood-stage immunity and why is it a new focus for malaria vaccines?
The immune response that targets the malaria parasite during the blood stage of the infection, when the parasite is multiplying within red blood cells.
It’s being used in combination with sporozoite immunity, because every sporozoite that slips through will lead to blood-stage infection.
What are anti-merozoite vaccines?
Merozoites are the form of the malaria parasite that are released from infected red blood cells and then invade other red blood cells.
Anti-merozoite vaccines stimulate the production of antibodies to prevent merozoites from invading red blood cells.
What are the 3 key challenges in developing blood-stage malaria vaccines?
- Antigenic polymorphism and redundant invasion pathways - need to identify better antigens for targeting.
- Need to learn more about the immunology.
- Need to induce an extremely high antibody concentration to protect, and to maintain this for a useful duration of immunity.
Why was the discovery of RH5 so fundamental in malaria vaccine development?
RH5 is the first conserved target within the blood-stage merozoite to be susceptible to vaccine-induced antibodies.
As it’s conserved, it makes it like the Achilles’ heel of malaria.
How has SpyTag technology been used in the development of malaria vaccines?
RH5 is a conserved target in blood-stage merozoites, and it was found that antibodies capable of killing the parasite do so most successfully when they block RH5’s ability to bind its receptor.
Antibodies can be created to block this binding site (called the tip), but inducing this via a vaccine was proving difficult.
SpyTag technology was used to decorate a hepatitis B vaccine with the tip protein instead. This saw a 10-fold improvement in antibody potency.
How has rapid progress been made with next-generation blood-stage vaccines?
- Identifying essential and conserved target antigens (e.g., RH5)
- Identifying assays that predict protective outcome and thereby enable rational protein vaccine design improvements.
- Optimizing design and delivery of protein/adjuvant vaccines to maximize quantity, quality and longevity of vaccine-induced antibody responses.
Define biological ageing.
The progressive loss of bodily function over time that increases the probability of death.
What causes Progeroid Werner syndrome?
Mutations in DNA repair, recombination and replication cause cells to undergo premature cell senescence.
This results in patients with gene expression patterns similar to those of an elderly person.
What is SIRT6 and how is it being targeted for age-related diseases?
SIRT6 is a protein that has been shown to regulate the ageing process by promoting genomic stability and suppressing cellular senescence.
- Small molecule activators of SIRT6
- Gene therapy to increase SIRT6 expression
How are senescent cells a driver of ageing pathology?
- Secrete collagenase, making invasion of blood vessels by cancer much easier
- Fail to repair DNA damage so tissue cannot be replaced
What are the therapeutic approaches to tackle cell senescence?
- Avoid telomere shortening
- Replace stem cells
- Reverse modifications leading to senescence to make them behave like ‘young’ cells
- Suppress inflammatory molecules
- Kill senescent cells